HeraMED Limited (ASX:HMD)

Australia flag Australia · Delayed Price · Currency is AUD
0.0410
-0.0010 (-2.38%)
At close: Mar 6, 2026
127.78%
Market Cap 45.66M
Revenue (ttm) 431.61K
Net Income (ttm) -4.13M
Shares Out 1.11B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 651,532
Average Volume 534,130
Open 0.0400
Previous Close 0.0420
Day's Range 0.0400 - 0.0410
52-Week Range 0.0060 - 0.0490
Beta 0.69
RSI 56.18
Earnings Date Feb 27, 2026

About HeraMED

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women’s health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Haw... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2011
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol HMD
Full Company Profile

Financial Performance

In 2025, HeraMED's revenue was 431,605, an increase of 18.47% compared to the previous year's 364,328. Losses were -4.13 million, -24.75% less than in 2024.

Financial Statements

News

There is no news available yet.